M. Usai

Delayed attainment of full donor chimaerism following alemtuzumab‐based reduced‐intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes

G. Mufti, K. Tobal, Z. Lim, 2007, British journal of haematology.

Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation

G. Caocci, G. la Nasa, M. Usai, 2017, Leukemia research reports.

Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis

G. Caocci, G. la Nasa, M. Usai, 2016, Leukemia & lymphoma.

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes

G. Morgan, D. Catovsky, D. Gonzalez, 2013, Haematologica.

Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse

T. Haferlach, M. Voso, F. Lo‐Coco, 2019, American journal of hematology.

Mixed donor chimaerism in recipient fingernails following reduced-intensity conditioning haematopoietic SCT

G. Mufti, Z. Lim, L. Pearce, 2008, Bone Marrow Transplantation.